Daniel Liebler
Faculty Member
Last active: 2/15/2016

  1. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL (2012) Oncogene 31(22): 2750-60
    › Primary publication · 21963845 (PubMed)
  2. A Reporter System for Translational Readthrough of Stop Codons in Human Cells. Halvey PJ, Liebler DC, Slebos RJ (2012) FEBS Open Bio : 56-59
    › Primary publication · 22563532 (PubMed) · PMC3342693 (PubMed Central)
  3. Supporting tool suite for production proteomics. Ma ZQ, Tabb DL, Burden J, Chambers MC, Cox MB, Cantrell MJ, Ham AJ, Litton MD, Oreto MR, Schultz WC, Sobecki SM, Tsui TY, Wernke GR, Liebler DC (2011) Bioinformatics 27(22): 3214-5
    › Primary publication · 21965817 (PubMed) · PMC3208394 (PubMed Central)
  4. Sequence tagging reveals unexpected modifications in toxicoproteomics. Dasari S, Chambers MC, Codreanu SG, Liebler DC, Collins BC, Pennington SR, Gallagher WM, Tabb DL (2011) Chem Res Toxicol 24(2): 204-16
    › Primary publication · 21214251 (PubMed) · PMC3042045 (PubMed Central)
  5. Safety assessment of xylene sulfonic acid, toluene sulfonic acid, and alkyl aryl sulfonate hydrotropes as used in cosmetics. Bergfeld WF, Belsito DV, Klaassen CD, Hill R, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30(6 Suppl): 270S-83S
    › Primary publication · 22247238 (PubMed)
  6. Safety assessment of cyclomethicone, cyclotetrasiloxane, cyclopentasiloxane, cyclohexasiloxane, and cycloheptasiloxane. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30(6 Suppl): 149S-227S
    › Primary publication · 22247236 (PubMed)
  7. Relating protein adduction to gene expression changes: a systems approach. Zhang B, Shi Z, Duncan DT, Prodduturi N, Marnett LJ, Liebler DC (2011) Mol Biosyst 7(7): 2118-27
    › Primary publication · 21594272 (PubMed) · PMC3659419 (PubMed Central)
  8. Protein-selective capture to analyze electrophile adduction of hsp90 by 4-hydroxynonenal. Connor RE, Marnett LJ, Liebler DC (2011) Chem Res Toxicol 24(8): 1275-82
    › Primary publication · 21749116 (PubMed) · PMC3155980 (PubMed Central)
  9. Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Rexer BN, Ham AJ, Rinehart C, Hill S, Granja-Ingram Nde M, González-Angulo AM, Mills GB, Dave B, Chang JC, Liebler DC, Arteaga CL (2011) Oncogene 30(40): 4163-74
    › Primary publication · 21499296 (PubMed) · PMC3204390 (PubMed Central)
  10. Painting a moving picture: large-scale proteomics efforts and their potential for changing patient care. Hoofnagle AN, Aebersold R, Anderson NL, Felsenfeld A, Liebler DC (2011) Clin Chem 57(10): 1357-60
    › Primary publication · 21540400 (PubMed)